|
|
肠道菌群与缺血性脑卒中关系的研究进展 |
邓美霞, 王敏, 潘政, 石正洪 |
730030,兰州大学第二医院神经内科 |
|
[1] |
Paul S, Candelario J E. Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies[J]. Exp Neurol, 2021, 335: 113518.
|
[2] |
Hasain Z, Mokhtar N M, Kamaruddin N A, et al. Gut microbiota and gestational diabetes mellitus: a review of host-gut microbiota interactions and their therapeutic potential[J]. Front Cell Infect Microbiol, 2020, 22(10): 188.
|
[3] |
Cryan J F, O′riordan K J, Cowan C S M, et al. The microbiota-gut-brain axis[J]. Physiol Rev, 2019, 99(4): 1877-2013.
|
[4] |
Gentile C L, Weir T L. The gut microbiota at the intersection of diet and human health[J]. Science, 2018, 362(6416): 776-780.
|
[5] |
Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota[J]. Nature, 2018, 555(7695): 210-215.
|
[6] |
Tang Q, Cao L. Intestinal flora and neurological disorders[J]. Sheng Wu Gong Cheng Xue Bao, 2021, 37(11): 3757-3780.
|
[7] |
Li C, Pi G, Li F. The role of intestinal flora in the regulation of bone homeostasis[J]. Front Cell Infect Microbiol, 2021, 11: 579323.
|
[8] |
Zeng X, Gao X, Peng Y, et al. Higher risk of stroke is correlated with increased opportunistic pathogen load and reduced levels of butyrate-producing bacteria in the gut[J]. Front Cell Infect Microbiol, 2019, 15(9): 4.
|
[9] |
Yamashiro K, Tanaka R, Urabe T, et al. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke[J]. PLoS One, 2017, 12(2): e0171521.
|
[10] |
Din A U, Hassan A, Zhu Y, et al. Amelioration of TMAO through probiotics and its potential role in atherosclerosis[J]. Appl Microbiol Biotechnol, 2019, 103(23-24): 9217-9228.
|
[11] |
Yan X, Jin J, Su X, et al. Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension[J]. Circ Res, 2020, 126(7): 839-853.
|
[12] |
Wu C, Li C, Zhao W, et al. Elevated trimethylamine N-oxide related to ischemic brain lesions after carotid artery stenting[J]. Neurology, 2018, 90(15): e1283-e1290.
|
[13] |
Haghikia A, Li X S, Liman T G, et al. Gut microbiota-dependent trimethylamine n-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes[J]. Arterioscler Thromb Vasc Biol, 2018, 38(9): 2225-2235.
|
[14] |
Nam H S. Gut microbiota and ischemic stroke: the role of trimethylamine N-oxide[J]. J Stroke, 2019, 21(2): 151-159.
|
[15] |
Stanley D, Moore R J, Wong C H Y. An insight into intestinal mucosal microbiota disruption after stroke[J]. Sci Rep, 2018, 8(1): 568.
|
[16] |
Chen Y, Liang J, Ouyang F, et al. Persistence of gut microbiota dysbiosis and chronic systemic inflammation after cerebral infarction in cynomolgus monkeys[J]. Front Neurol, 2019, 16(10): 661.
|
[17] |
Wen S W, Wong C H Y. An unexplored brain-gut microbiota axis in stroke[J]. Gut Microbes, 2017, 8(6): 601-606.
|
[18] |
Li N, Wang X, Sun C, et al. Change of intestinal microbiota in cerebral ischemic stroke patients[J]. BMC Microbiol, 2019, 19(1): 191.
|
[19] |
Tan B Y Q, Paliwal P R, Sharma V K. Gut microbiota and stroke[J]. Ann Indian Acad Neurol, 2020, 23(2): 155-158.
|
[20] |
Houlden A, Goldrick M, Brough D, et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production[J]. Brain Behav Immun, 2016, 57(5): 10-20.
|
[21] |
Zhang Z, Zhang Y, Li J, et al. The neuroprotective effect of tea polyphenols on the regulation of intestinal flora[J]. Molecules, 2021, 26(12):135-141.
|
[22] |
Benakis C, Brea D, Caballero S, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells[J]. Nat Med, 2016, 22(5): 516-523.
|
[23] |
Singh V, Sadler R, Heindl S, et al. The gut microbiome primes a cerebroprotective immune response after stroke[J]. J Cereb Blood Flow Metab, 2018, 38(8): 1293-1298.
|
[24] |
Klimiec E, Pasinska P, Kowalska K, et al. The association between plasma endotoxin, endotoxin pathway proteins and outcome after ischemic stroke[J]. Atherosclerosis, 2018, 269: 138-143.
|
[25] |
Liu Y, Kong C, Gong L, et al. The association of post-stroke cognitive impairment and gut microbiota and its corresponding metabolites[J]. J Alzheimers Dis, 2020, 73(4): 1455-1466.
|
[26] |
Xu J, Cheng A, Song B, et al. Trimethylamine n-oxide and stroke recurrence depends on ischemic stroke subtypes[J]. Stroke, 2022,53(4): 1207-1215.
|
[27] |
Kim S K, Guevarra R B, Kim Y T, et al. Role of probiotics in human gut microbiome-associated diseases[J]. J Microbiol Biotechnol, 2019, 29(9): 1335-1340.
|
[28] |
Chen R, Xu Y, Wu P, et al. Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota[J]. Pharmacol Res, 2019, 148: 104403.
|
[29] |
Huang J T, Mao Y Q, Han B, et al. Calorie restriction conferred improvement effect on long-term rehabilitation of ischemic stroke via gut microbiota[J]. Pharmacol Res, 2021, 170(12): 105726.
|
[30] |
赵晓鹏,杜红珍,谢 颖,等.益生菌制剂对脑卒中患者肠道菌群及肠道功能影响的Meta分析[J].中国微生态学杂志,2021,33(10):1139-1146.
|
[31] |
Lee J, D′aigle J, Atadja L, et al. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice[J]. Circ Res, 2020, 127(4): 453-465.
|
[32] |
Singh V, Roth S, Llovera G, et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke[J]. J Neurosci, 2016, 36(28): 7428-40.
|
[33] |
Roberts A B, Gu X, Buffa J A, et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential[J]. Nat Med, 2018, 24(9): 1407-1417.
|
[1] |
庄伟, 董玉茹. 肠内营养联合益生菌对中重度溃疡性结肠炎的疗效[J]. 武警医学, 2020, 31(11): 973-975. |
[2] |
毛从答,李玲玲,牛兆青,张海茂. 血清RBP4、MCP-1、SAA水平变化与缺血性脑卒中老年患者NIHSS评分的相关性[J]. 武警医学, 2019, 30(8): 693-696. |
[3] |
杨春梅, 刘圆圆. 载脂蛋白E基因多态性与初发急性缺血性脑卒中的相关性及其对近期预后的影响[J]. 武警医学, 2019, 30(6): 518-520. |
[4] |
刘芊, 潘琦. 经肠镜右半结肠单次喷洒益生菌混悬液对腹泻型肠易激综合征的疗效及安全性[J]. 武警医学, 2019, 30(4): 329-333. |
[5] |
范琼丽, 李文藻, 吴至凤, 张雨平, 余秀梅. 肠道菌群在儿童孤独症中的研究进展[J]. 武警医学, 2019, 30(11): 1001-1003. |
[6] |
李晟, 陈宏, 孙岩, 陈丁, 田红霞, 袁鹰, 肖王艳. 维持性血液透析终末期肾病患者肠道菌群特点探讨[J]. 武警医学, 2019, 30(10): 838-841. |
[7] |
杨振威. 祛瘀化痰通腑方治疗缺血性脑卒中恢复期的临床研究[J]. 武警医学, 2017, 28(8): 789-791. |
[8] |
姚响文, 王金余, 吴之琳, 牛筛龙. 脑康口服液治疗缺血性脑卒中后继发神经功能损害的疗效[J]. 武警医学, 2017, 28(3): 251-253. |
[9] |
薄茂林, 薛芝兰, 张涛. 3种益生菌制剂联合美沙拉秦口服治疗轻中度溃疡性结肠炎疗效[J]. 武警医学, 2017, 28(10): 980-984. |
[10] |
周仙杰,李军,鲁飞翔,夏靖媛,刘庆春. 间歇式低氧对主动脉弓缩窄模型小鼠肠道菌群的影响[J]. 武警医学, 2016, 27(11): 1121-1125. |
[11] |
牛天天, 唐红卫. 益生菌用于重度急性胰腺炎治疗的Meta分析[J]. 武警医学, 2015, 26(6): 576-579. |
[12] |
柳迎春. 阿加曲班治疗急性缺血性脑卒中的有效性及安全性[J]. 武警医学, 2015, 26(2): 124-126. |
[13] |
王乾综述伏洁审校. 益生菌在新生儿期的临床应用[J]. , 2014, 25(6): 617-619. |
[14] |
孟令海,尚淑玲,张贺齐,李迥,于心洋. 缺血性脑卒中合并冠心病患者院外用药依从性调查[J]. 武警医学, 2013, 24(7): 631-632. |
[15] |
孟令海,李 迥,张贺齐,尚淑玲,于心洋. 唐山地区缺血性脑卒中患者二级预防用药现况调查[J]. 武警医学, 2012, 23(9): 761-762. |
|
|
|
|